Article info
PDFCommentary
General medicine
Optimal anticoagulant treatment of cancer-associated venous thromboembolism remains unclear
- Correspondence to Dr Hanny Al-Samkari, Division of Hematology, Massachusetts General Hospital, Harvard Medical School, Boston MA 02114, USA; hal-samkari{at}mgh.harvard.edu
Citation
Optimal anticoagulant treatment of cancer-associated venous thromboembolism remains unclear
Publication history
- First published December 5, 2018.
Online issue publication
May 22, 2019
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.